Fox Business - The Power to Prosper
Search Site

Baxter International

Baxter International 2Q earnings beat expectations

Earnings HQ: FBN’s Lori Rothman breaks down Baxter International ’s second-quarter earnings report.

Read More

  1. Why I sold Baxter and CareFusion

    The Covestor Healthcare portfolio that I manage did not escape the effects of the August sell-off which resulted in a 3.5% loss for the S&P 500 Index (SPX), the bigg...

  2. Aveo: Anatomy of a trade gone wrong

    Riding on the back of a strong market, the TenStocks portfolio racked up decent year-to-date gains coming into late April. As qualifying investments became harder to...

  3. Baxter's Potential Alzheimer's Treatment Immunoglobulin Misses Primary Endpoints

    Baxter International Inc. (BAX) said results from a late-stage study of its potential treatment for Alzheimer's, immunoglobulin, were negative.The results didn't mee...

  4. Health-Care Companies Report Slowdown in Patient Visits

    The spike late last year in doctor and hospital visits apparently lasted as long as the flu.After years of decelerating health-care usage--linked to economic problem...

  5. Baxter's Sales Rise, But Health-Care Pressures Remain

    Baxter International Inc. (BAX) reported a slight increase in first-quarter sales, as growth in emerging markets helped to offset continued pricing and utilization p...

  6. Baxter 1st-Quarter Profit Off 11% on Acquisition-Related Charges

    Baxter International Inc.'s (BAX) first-quarter earnings fell 11% as the medical-products company was hurt by acquisition-related charges and the year-earlier period...

  7. Market Wrap for Friday, March 22: Stocks Rise on Hopes of Bailout Deal for Cyprus

    The U.S. stock market closed out a choppy week with a gain as policymakers in Cyprus were in talks with EU officials to secure a bailout for the Mediterranean island...

  8. Gentium Gets Negative Opinion From CHMP; Biogen, Others Get Positive Opinions

    Gentium SpA (GENT) said the European Medicines Agency's Committee for Medicinal Products for Human Use issued a negative opinion, recommending the refusal of marketi...

  9. Insight - A casualty of the financial crisis: The corporate palace

    In the past year, defense company SAIC Inc has shrunk the office space it either owns or leases by 306,000 square feet (28,428 sq meters), the size of about five foo...

  10. CSL Beats Expectations With 24% Increase in 1st Half Net Profit

    CSL Ltd. (CSL.AU), one of the world's biggest manufacturers of blood plasma and flu vaccines, said Wednesday its first half profit rose 24% as it capitalized on a ri...

  11. Cangene Wins Auction for Inspiration's Hemophilia Drug

    Inspiration Biopharmaceuticals Inc. reached a deal to sell its second development-stage hemophilia drug at auction Tuesday to Cangene Corp. for $5.9 million in cash ...

  12. Investor Raises Dividend as 4Q NAV/Share Rises 12% on Year

    Investor AB (INVE-B.SK), the Swedish investment company, Tuesday posted a 12% on-year rise in net asset value per share and raised its dividend, adding that it aims ...

  1. How we keep our portfolio free of exuberance

    An old adage in the financial markets for seekers of value is 'follow the misery.' The concept of misery is subjective and means different things to different people...

  2. Investing lessons from the biotech rout

    The Healthcare Model on Covestor had a challenging month in March and into early April, 2014.  As of April 3, 2014, the model while down 6.3% for the prior 30 days. ...

  3. Baxter to Split Itself into Two Companies

    Baxter International (NYSE:BAX) unveiled plans on Thursday to split itself into two separate companies, creating an independent biopharmaceuticals firm.A second comp...

  4. Merck Snags Baxter Executive As CFO

    Merck (NYSE:MRK) tapped Baxter (NYSE:BAX) executive Robert Davis on Thursday to replace current finance head Peter Kellogg as the company struggles to revive sales a...

  5. Baxter to Develop Gene Fighter to Treat Leukemia

    Drug giant Baxter International (NYSE:BAX) inked a licensing partnership with smaller rival Cell Therapeutics (NYSE:CTI) on Friday to develop and commercialize a gen...

  6. 7 Jobs that Require Great Credit

    You've shined your shoes, know where you see yourself in five years and boned up on the firm's bigwigs. Before applying for that dream -- or even interim -- job, you...

  7. Medical Device Tax Has Got to Go

    Just how bad is a tax that treats pacemakers and CT scan machines as if they're alcohol or cigarettes?Last January 1, medical-device makers had to start paying a new...

‹ Prev12345Next ›
Freebase CC-BY
Source: Baxter International on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL